Neurocrine Biosciences CHRO sells shares worth $181,129

[
Neurocrine Biosciences CHRO sells shares worth $181,129
[og_img]
https://www.investing.com/news/insider-trading-news/neurocrine-biosciences-chro-sells-shares-worth-181129-93CH-3871714

Investing.com

What is NotebookLM: Power-up your research skills

How Samsung Knox protects appliances from security threats

Elon Musk says Grok 2 is going open source as he rolls out Grok 3 for Premium+ X subscribers only

Desky Dual Bamboo sit-stand desk review: an affordable, voice-controlled workplace essential

Ex-Israeli Intelligence Official: Shockwaves of Trump’s “Take Over Gaza” Heard, Felt Across Region

What UK political parties are promising in the 2019 general election

Otto Warmbier’s parents want North Korea to suffer for their son’s death

Could a ‘youthquake’ cause Boris Johnson to lose the general election?

Which Celebrity Styles Americans Copy Most in 2025: New Study

New ‘Westworld’ trailer introduces us to another dystopian tech company

What’s the point of ‘Charlie’s Angels’ without Sam Rockwell dancing?

These striking photos capture the future of human flight

US envoy Kellogg arrives in Ukraine for talks with Zelenskiy

Trump’s anti-DEI campaign hits universities: even sharing experiences of racism in college essays may be banned

Glencore falls 5% after missing EBITDA estimates, capital returns disappoint

BYD founder Wang Chuanfu, fresh from his meeting with Xi Jinping, claims Chinese EVs are 3 to 5 years ahead of the competition

The YouTuber who has become one of Gen Z’s most beloved celebrities

26 last-minute holiday gifts that are still thoughtful and unique

Practicing gratitude regularly can make you less stressed and sleep better

8 things millennials wish you would just stop getting them for the holidays

Neurocrine Biosciences CHRO sells shares worth $181,129

US envoy Kellogg arrives in Ukraine for talks with Zelenskiy

Trump’s anti-DEI campaign hits universities: even sharing experiences of racism in college essays may be banned

What is NotebookLM: Power-up your research skills

Glencore falls 5% after missing EBITDA estimates, capital returns disappoint

Leave a reply Cancel reply